Compare CCRN & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCRN | OCGN |
|---|---|---|
| Founded | 1986 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 408.7M | 419.8M |
| IPO Year | 2001 | 2014 |
| Metric | CCRN | OCGN |
|---|---|---|
| Price | $13.20 | $1.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $14.15 | $9.75 |
| AVG Volume (30 Days) | 503.9K | ★ 6.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.58 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $816,484,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.01 | $1,718.38 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.43 | $0.90 |
| 52 Week High | $14.98 | $2.73 |
| Indicator | CCRN | OCGN |
|---|---|---|
| Relative Strength Index (RSI) | 74.20 | 53.77 |
| Support Level | $13.02 | $1.30 |
| Resistance Level | $13.23 | $1.92 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 78.13 | 81.48 |
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").